Canaccord Genuity Starts ZELTIQ Aesthetics (ZLTQ) at Buy; Uniquely Positioned

Canaccord Genuity initiates coverage on ZELTIQ Aesthetics (NASDAQ: ZLTQ) with a Buy. PT $10.00.

Analyst, William J. Plovanic, said, "We believe Zeltiq is uniquely positioned in the aesthetics industry with a market-expanding, non-invasive treatment for fat cell removal. We believe the company’s first-to-market advantage, combined with good clinical outcomes, an easily repeatable procedure, and profitable economics for the physician office, strongly positions the therapy for physician and patient adoption."

For an analyst ratings summary and ratings history on ZELTIQ Aesthetics click here. For more ratings news on ZELTIQ Aesthetics click here.

Shares of ZELTIQ Aesthetics closed at $5.66 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
• Craig-Hallum Starts Red Robin Gourmet Burgers (RRGB) at Buy
• Northland Starts Bitfarms Ltd. (BITF) at Outperform